Week 4 Midterm Exam: NR546 / NR-
546 (Latest 2025 / 2026) Advanced Pharmacology Psychopharmacology for the PMHNP | Questions and Answers | 100% Correct | Grade A - Chamberlain
Question:
Which NTM is targeted by azapirones/buspirone
Answer:
5HT, DA, NE
Question:
S/E of buspirone
Answer:
dizziness HA sedation nervousness nausea 1 / 4
Question:
Monitoring of buspar
Answer:
severe renal and hepatic impairment concurrent use of MAOIs
Question:
True or false buspar causes sexual s/e
Answer:
false. Buspar may decrease sexual se when used in combination with an SSRI
Question:
MOA of Alpha 2 delta ligands
Answer:
bind with glutamate calcium change blockers to inhibit the release of several neurotransmitters
Question:
Alpha 2 delta ligands are FDA approve for treatment of anxiety
Answer:
False. Alpha 2 delta ligands are used off label for treatment of anxiety
- / 4
Question:
MOA of pregabalin for anxiety
Answer:
binds to the alpha 2 delta subunit of voltage-sensitive calcium channels.diminishing excessive neuronal activity and NTM release
Question:
Which drugs are alpha 2 delta ligands
Answer:
gabapentin, pregabalin
Question:
S/E of Alpha 2 delta ligands
Answer:
sedation dizziness impaired attention confusion dry mouth constipation blurred vision possible weight gain
- / 4
Question:
Precautions for A2 delta ligands
Answer:
suicidal ideation substance abuse heart failure renal failure
Question:
Contraindication for A2 delta ligands
Answer:
myopathy avoid prescribing concurrently wiht benzo
Question:
What is the onset of action for pregabalin in anxiety
Answer:
similar to onset of alprazolam
- / 4